The latest gynaecological cancer news
New Approach to Ovarian Cancer Treatment
Overall survival from ovarian cancer has not improved for several decades. Now, a Peter Mac-led…
The latest gynaecological cancer news
Overall survival from ovarian cancer has not improved for several decades. Now, a Peter Mac-led…
Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of…
In a small, phase II study of a very rare cancer that develops inside a…
A team of researchers at Tufts University’s School of Engineering and its School of Medicine,…
The rogue cellular engine that drives a majority of ovarian cancers remains frustratingly difficult to…
Offering personalised ovarian cancer risk prediction to women shows that 98 per cent of participants…
Peter Mac researchers have been awarded a four year grant from the Federal Government’s Medical…
Maintenance therapy with olaparib extended overall survival by nearly 13 months (12.9) compared with placebo…
The Food and Drug Administration (FDA) expanded the indication of olaparib to include its combination…
The Food and Drug Administration (FDA) approved niraparib for the maintenance treatment of adult patients…